CRIS Q1 2026 Earnings Significant EPS Miss Amidst Operational Updates Laird Superfood Inc Q1 2026 Earnings Surprise Profitability Demonstrated Through Strong Cost Controls DTE Q1 2026 Earnings EPS Misses Estimates Amid Regulatory and Operational Headwinds Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment FBIN Q1 2026 Earnings Slight EPS Miss as Housing Headwinds Persist Shares Edge Higher ODV Q1 2025 Earnings EPS Misses Estimates as PreRevenue Developer Reports Net Loss